Calgary Scientific, ClearCanvas form alliance

TriMed Staff | | Health Imaging | Artificial Intelligence
ClearCanvas, a developer of open-source healthcare applications, and Calgary Scientific Medical Group, a provider of advanced visualization and analysis software, announced a strategic alliance at the 2008 Society of Imaging Informatics of Medicine (SIIM) meeting in Seattle.

Norman Young, president of the Toronto-based ClearCanvas said that the Calgary, Alberta-based Calgary Scientific has embraced the extensible open-source RIS/PACS platform by building a set of commercial advanced visualization tools. “Their powerful, intuitive tools are a welcome addition to what we hope will be a thriving ecosystem that includes both open source and commercial add-ins,” Young added.

“ClearCanvas and their open-source model represent a very innovative approach for expanding access to healthcare technology and improving its capabilities. Our goal from the beginning has been to improve the value of medical imaging by developing user-friendly advanced visualization tools and making them more accessible to radiologists, physicians and ultimately patients,” said Byron Osing, MD, CEO of Calgary Scientific.

TriMed Staff

Related Content

Mayo Clinic and Microsoft partner to advance generative AI in radiology
ACR partners to create AI foundational model assessment website
Could synthetic images replace the need for contrast?
Experts developing AI model that learns from calcium-scoring CT scans
FDA has approved over 1,000 clinical AI applications, with most aimed at radiology
Commercially available AI increases breast cancer detection by nearly 20%

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.